Sunday, 26 May 2019

Most Popular
Pharma News
BioTech News
MedTech News
BioServices News
Video Gallery

Inside Magazine

3Ps augmenting drug discovery in APAC

Beyond meeting the needs of global pharma in simply providing access to patient pools and lower operational costs, the Asia-Pacific (APAC) region is also poised to realize the potential of a thriving biotechnology sector that is driving innovation on its own. APAC is gaining the experience and infrastructure needed to support the global biotech industry by performing work and fostering innovation through public private partnership (3Ps) that is moving up the pharmaceutical value chain.

Sign up here to access BioSpectrum Asia flip book.